HOLX Chart
- 52-Week Range: $60.52 - $80.74
- Market Capitalization: $19.48B
- Short Percentage: 0%
- Target Price: $79.60
- Shares Outstanding: 249.38M
- Next Earnings: Jan 26
Catalysts
CategoryCatalyst
Earnings
HOLX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Hologic Announces FDA Approval of Aptima® CMV Quant Assay for Human CytomegalovirusBusiness Wire | May 10th
- Hologic, Inc. (HOLX) CEO Steve MacMillan on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha | April 27th
- Peng Shuai controversy was ‘catalyst' for Hologic sponsorship of WTA, CEO saysYahoo Finance | March 9th
- Hologic's Underperformance Makes This A Name Worth Further ConsiderationSeeking Alpha | February 17th
- Hologic, Inc. (HOLX) CEO Stephen MacMillan on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | February 2nd
Company Info
Website: https://www.hologic.com
Address: 250 Campus Drive, Marlborough, MA, United States, 01752
Sector: Healthcare
Industry: Medical Instruments & Supplies
Full time employees: 6,705
Address: 250 Campus Drive, Marlborough, MA, United States, 01752
Sector: Healthcare
Industry: Medical Instruments & Supplies
Full time employees: 6,705
$HOLX Buy the dip
$HOLX It's coming
load 'em up.
$HOLX Awaiting buy signal..
$HOLX wtf?
$HOLX when's the offering?
$HOLX i like the stock
$HOLX death cross will complete today
$HOLX I still don’t wanna buy it
$HOLX breaking out of this wedge sooner than later
$HOLX Nope